Well, well. As per the March 18 PR, “GenViro
Post# of 11803
(Total Views: 374)
Posted On: 03/20/2020 9:33:01 PM
Well, well.
As per the March 18 PR, “GenViro!™ has been validated at the company's R&D center in Daegu, Korea for the H5N1 virus and most recently the methodologically similar corona virus.”
So as I understand the Product Development cycle after 30+ years I would be hardpressed to understand a fail based on this presser; esp. after the series of PRs.
Now, I’m not familiar with micro cap manufacturing of diabetic or virus test kits and strips but if $13M get 525M or even 420M kits (of a 2 product portfolio) that would be more than impressive esp. in a 6 month period. So, it seems more than likely that a licensing agreement or partnership or M&A must be on the near term horizon to support this type of volume. But what do I know? I’m just an 8 year investor, who didn’t sell at .60 and waited patiently for the portfolio to translate to sales. Still waiting. See we all aren’t stock traders. I’m no fan of stock traders but they have a place and guess what, stock traders and investors both want to make a return on their investment. Only irrational, egotistical, message board pompous asses think differently.
As you said, KB can now spend like a drunken sailor. Think we all hope that’s not the case, but you know him better than most. I, along with many, am certain the can of worms that has been opened by KB will be baited to reel in virus testing sales and likely a big fish.
Many are counting on DECN to deliver. I think they will.
As my friend says, traders should trade, engineers should engineer, marketeers should market and obnoxious message board posters should check their blood pressure and spend some time in Church.
Well, well. Stay well.
As per the March 18 PR, “GenViro!™ has been validated at the company's R&D center in Daegu, Korea for the H5N1 virus and most recently the methodologically similar corona virus.”
So as I understand the Product Development cycle after 30+ years I would be hardpressed to understand a fail based on this presser; esp. after the series of PRs.
Now, I’m not familiar with micro cap manufacturing of diabetic or virus test kits and strips but if $13M get 525M or even 420M kits (of a 2 product portfolio) that would be more than impressive esp. in a 6 month period. So, it seems more than likely that a licensing agreement or partnership or M&A must be on the near term horizon to support this type of volume. But what do I know? I’m just an 8 year investor, who didn’t sell at .60 and waited patiently for the portfolio to translate to sales. Still waiting. See we all aren’t stock traders. I’m no fan of stock traders but they have a place and guess what, stock traders and investors both want to make a return on their investment. Only irrational, egotistical, message board pompous asses think differently.
As you said, KB can now spend like a drunken sailor. Think we all hope that’s not the case, but you know him better than most. I, along with many, am certain the can of worms that has been opened by KB will be baited to reel in virus testing sales and likely a big fish.
Many are counting on DECN to deliver. I think they will.
As my friend says, traders should trade, engineers should engineer, marketeers should market and obnoxious message board posters should check their blood pressure and spend some time in Church.
Well, well. Stay well.
(5)
(0)